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Introduction
 1 
 
1 Enzyme promiscuity 
For decades, the paradigm of one enzyme catalyzing one specific 
reaction on one specific substrate, dominated (and still dominates) 
the textbooks. However, the idea that enzymes are able to catalyze 
other reactions on substrates different from the ones for which 
they have physiologically evolved, is undeniably not new: in 1976 
Jensen first hypothesized that, unlike “modern” enzymes, ancestral 
ones possessed extensive cross-reactivity toward a broad range of 
substrates [1]; thus, relatively few primitive enzymes could act on 
multiple substrates allowing a wider  metabolic potential [2]. 
Traces of this peculiarity can still be witnessed today, in the form 
of low secondary activities toward “unnatural” substrates [3]. 
Enzyme promiscuity is defined as the presence of auxiliary 
catalytic activities, in addition to the one for which an enzyme has 
evolved, that are not part of the canonical organism’s metabolism. 
Thus, enzymes which “naturally” evolved to transform a wide 
variety of substrates, must not be considered promiscuous: they 
are multispecific or broad-specificity enzymes [2]. Promiscuous 
activities generally rely on the same active site features 
responsible for the native activity, and although differences may 
exist, such as the mode of substrate binding, the reaction 
mechanism is, in many cases, similar. From a thermodynamic point 
of view, specific enthalpy-driven interactions, such as hydrogen 
bonds, play a relevant role in the binding of the native substrate, 
while aspecific hydrophobic interactions are thought to prevail for 
the promiscuous substrates. The existence of promiscuous 
functions can be explained by the fact that enzymes exhibit a 
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“rugged” energy landscape with many local minima: these minima 
correspond to a set of different protein conformations with similar 
but discrete energy levels, that exchange one another in an 
equilibrium regulated by the binding of different substrates (Fig. 
1) [4]. The conformation of the enzyme which binds the native 
ligand is the “native” state, while other (less represented) 
conformers bind promiscuous ligands and catalyze alternative 
reactions [2]. 
 
 
 
 
 
 
 
 
 
The amplitude of such promiscuous activities can vary over 
several orders of magnitude in terms of catalytic efficiency (i.e. the 
ratio between turnover number and Michaelis constant), ranging 
from the same level of the native activity, as in the case of the 
promiscuous aryl esterase activity of serum paraoxonase PON1 [5] 
to an activity which is many orders of magnitude lower that the 
native one (e.g., the activity of dihydroorotase on 
phosphotriesters) [6]. 
The promiscuity of an enzyme can be quantified by a parameter 
called degree of promiscuity, which defines the level of “breach” of 
Figure 1 – Schematic representations of energy landscapes of enzymatic proteins. 
A) The classical protein landscape showing a unique global minimum 
(corresponding to a unique conformation). B) The ‘modern view’ assumes the 
existence of an ensemble of conformations possessing similar free energy. C) These 
conformations are in an equilibrium; the binding of different (e.g. promiscuous) 
substrates shifts this equilibrium towards different specific conformations [4]. 
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the enzyme specificity, that is related to the extent promiscuous 
activities of a given enzyme differ from the native activity. The 
degree of promiscuity can be assessed by examining the differences 
in the catalytic mechanisms between the native and promiscuous 
reactions. Interestingly, an enzyme can possess more than one 
Enzyme Commission (EC) number; the comparison of the 
differences in these numbers could reveal promiscuous activities; 
differences from the native one in the first digit of the EC number 
indicate a different reaction mechanism and differences in the 
second or third digits indicate different classes of substrates [2]. 
Promiscuity has been also studied on non-enzymatic proteins, for 
example anbibodies or receptors. Antigen-antibody or receptor-
ligand binding studies are much easier to perform in comparison 
to high throughput screenings for promiscuous enzymatic 
activities, due to the possibility to exploit a single detection 
protocol suitable for the whole range of studied interactions. 
These studies revealed that antibodies, thought to be strictly 
monospecific, are instead capable to bind, although with a lower 
affinity, a wide array of structurally unrelated antigens [7, 8], an 
observation also supported by theoretical or computational 
models [9]. It is reasonable to extend the results of these studies 
also to enzymatic proteins and, consequently, it is plausible that 
most enzymes exhibit a certain range of promiscuous functions, 
making promiscuity a general phenomenon which should be 
regarded as a rule, rather than an exception. 
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1.1 Classification of enzyme promiscuity 
Three main kinds of promiscuity can be observed in enzymes: 
condition promiscuity, substrate promiscuity and catalytic 
promiscuity (Table 1) [3]. 
 
 
 
 
 
 
 
 
 
 
 
1.1.1 Condition promiscuity 
Condition promiscuity is defined as the ability of an enzyme to 
catalyze reactions in an environment different from the one in 
which it was evolved, such as organic solvents, high temperatures, 
or extreme pHs. Indeed, taking to the extreme this assumption, 
every reaction performed in laboratory can be considered an 
example of “condition promiscuous” activity: outside of the cell 
enzymes are exposed to reaction environments different from the 
in vivo ones, at least because of the presence of a buffering system 
which is obviously different from the cytoplasm of the cell [3]. 
An early example of exploitation of the condition promiscuity of 
enzymes is represented by the studies on the stability and activity 
Table 1. Examples of different kinds of promiscuity. Catalytic promiscuity is 
split into accidental and induced promiscuity. Adapted from [3]. 
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of the serine protease subtilisin E in the polar organic solvent 
dimethylformamide (DMF). Under these conditions (i.e. in the 
absence of water) hydrolysis is suppressed and the enzyme is 
forced to catalyze the reverse reaction, that is the condensation 
reaction, leading to peptide synthesis. The performance of the 
enzyme in an organic solvent was improved by several rounds of 
directed evolution, which eventually produced an enzyme 
possessing an activity 256-fold higher in comparison to the wild 
type [10] (Table 1). 
Also pH plays an important role in modulating the reactivity of an 
enzyme because the same active site residue can work in a 
different protonation state between the native and the 
promiscuous function, allowing the catalysis of different chemical 
reactions. As an example, proline 1 of of 4-oxalocrotonate 
tautomerase possesses a pKa of about 6.4 and mainly acts as a 
general base; however, at pH 7.8, a small fraction of proline 1 is 
present in the protonated state exhibiting a weak but detectable 
promiscuous hydratase activity by general acid catalysis [11]. 
 
1.1.2 Substrate promiscuity 
In many cases, promiscuous activities share the same active-site 
configuration and features of the native activity. The differences 
between the higher catalytic efficiency on the native substrates 
versus lower activities on the promiscuous ones, originate from a 
different mode of interaction of the substrates with the active site 
residues. As an example, alkaline phosphatase efficiently catalyzes 
the hydrolysis of phosphate monoesters but it is also able to 
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promiscuously catalyze hydrolysis reactions of phosphodiesters, 
phosphoamides, sulfate esters and phosphite, using the same 
reaction mechanism which involves the nucleophilic attack of the 
substrate by Ser102 forming an intermediate which is stabilized 
by the interaction with a Zn2+ and Arg166. These interactions are 
much more favorable for the native substrates than for the 
promiscuous ones, explaining the observed different reaction rates 
[12]. 
Sometimes, changing the enzyme cofactor, especially in the case of 
metal ions, can alter the enzyme specificity; as an example, in 
carbonic anhydrase, the substitution of the native Zn2+ with Mn2+ 
allows the catalysis of styrene epoxidation, while the substitution 
of Zn2+ with Rh2+ converts this enzyme into a hydrogen-utilizing 
reductase [13, 14]. 
 
1.1.3 Catalytic promiscuity 
The term catalytic promiscuity defines the ability of a single active 
site to catalyze more than one chemical reaction that can differ in 
the type of bond that is formed or cleaved during the reaction 
and/or in the catalytic mechanism; these differences result into 
the formation of different transition states [15]. 
An example is represented by aminopeptidase P, a 
metallopeptidase which natively catalyzes the hydrolysis of amide 
C–N bonds, but is also able to catalyze the hydrolysis of phosphate 
triesters (a P–O bond) which implies the stabilization of a 
transition state with different geometry [16]. 
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Catalytic promiscuity can be further divided into two main 
categories: in most cases the wild-type enzyme is already able to 
catalyze more than one reaction; this property is defined as 
accidental catalytic promiscuity. On the other hand, often a new 
enzymatic activity is acquired or enhanced due to the 
accumulation of one or more point mutations that modify the 
reaction catalyzed by the wild-type enzyme. This event is defined 
as induced catalytic promiscuity [3].  
 
1.2 Enzyme promiscuity and the evolution of molecular 
biodiversity. 
It is now widely accepted that enzyme promiscuity might 
represent the starting point for the divergent evolution of new 
protein functions. Several evidences suggest that most, 
contemporary enzyme families and superfamilies have evolved 
from promiscuous multi-functional ancestral enzymes, from which 
specificity (first) and efficiency (later) stemmed through 
divergence and evolutionary optimization, respectively [17]. First, 
in many cases, the same promiscuous activity can be retrieved in 
more than one member of an enzyme family [18]: the native 
function of one family member represents often a promiscuous 
activity in other family members. This overlap is a consequence of 
the common catalytic strategy that defines these families as a 
consequence of the origin of the family members from the same 
gene (divergent evolution) [19]. Second, in vitro evolution of one 
promiscuous activity often yields a “generalist” intermediate that 
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follows a new specialization, indirectly leading to the appearance 
of other promiscuous activities [20] (Fig. 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The above observations support the hypothesis that  all existent 
proteins originated by divergent evolution from a small set of 
progenitors which conceivably formed the original protein pool of 
the ancestral microorganism defined as last universal common 
ancestor (LUCA) [1]. 
The existence of promiscuous activities is a prerequisite for the 
evolution of new functions. Thus molecular evolution is likely to 
happen through nature ‘tinkering with’ genes to generate new 
protein structures and functions by improving and by constantly 
Figure 2. Ancestral enzymes are believed to display several low original activities 
(termed a, b, c, d); during evolution they have been subjected to selection pressures 
for those activities, thus duplicating and diverging into a family of highly specialized 
enzymes activities (denoted as uppercase letters A, B, C, D, E, F). ‘Modern’ enzymes 
may still retain some of the original activities of the ancestral ones (denoted in lower 
case), as promiscuous activities. These activities are shared among the members of 
the family, and in some case the native activity of one member is the promiscuous 
activity of another, and vice versa [25]. 
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perfecting their promiscuous activities. The introduced mutations 
must confer a selective advantage to the organism from the very 
onset of the evolutionary process, otherwise they could not be 
positively selected and, in turn, transmitted during evolution [4]. 
Secondary activities eliminate the necessity to generate a new 
enzyme from scratch and their presence can potentially provide an 
immediate selective advantage to the organism. In fact, 
promiscuity plays a biological role in enabling organisms to 
survive changes in environment and contributes to the tolerance 
of some organisms to deletions of genes coding for proteins 
involved in metabolic pathways [21]. 
Once a promiscuous function acquires a physiological relevance, 
its efficiency can be enhanced by the accumulation of mutations in 
the corresponding gene. This process must happen, at least in the 
first stages, without any significant detrimental effect on the native 
function of the enzyme [2]. 
According to the most widely accepted model for divergent 
evolution of proteins, a gene duplication event results into the 
appearance of a redundant gene copy, that is relieved from 
selective pressure and, consequently, it is free to accumulate both 
beneficial and deleterious mutations [22]. It is estimated though, 
that more than 30 % of random mutations in a gene are 
deleterious for the function of the encoded protein [23], while 
beneficial mutations that enhance a novel function are much more 
rare, with an estimated frequency of ∼10−3. It follows that, if a gene 
could accumulate mutations in the absence of any selection, the 
probability to produce a non-functional protein would be some 
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orders of magnitude higher than that to obtain (or improve) a new 
function. Accordingly, enzymes, to be able to evolve, must display 
two crucial, yet apparently conflicting, features: plasticity, that is 
the ability to gain new functions through the accumulation of a 
relatively low number of mutations, and robustness, that is the 
ability to tolerate negative structural or functional changes 
induced by the effect of detrimental mutations [5]. 
Promiscuous enzymatic activities are highly plastic; they can be 
modified through mutations that dramatically increase or decrease 
them: following the introduction of only few mutations, these 
activities can be enhanced by 10–1000-fold, but reports of 104–
106-fold increases, following a single mutation, have also been 
described [24]. The high plasticity of these activities is due to the 
fact that the mutated residues are often located on surface loops 
that are part of the substrate binding pocket and exhibit high 
conformational flexibility. Usually these residues are not part of 
the protein’s scaffold or of the catalytic machinery of the enzyme. 
Their localization can also explain the different effects that 
mutations of these residues have on the native versus the 
promiscuous functions: in many cases, the enhancement of the 
promiscuous functions does not seem to correlate with an equal 
decreases in the original function’s activity [5]: contrary to the 
large changes undergone by promiscuous activities, the effects of 
the same mutations on the native functions are limited. In most 
cases, the ratio between the increase in catalytic efficiency of a 
promiscuous function to the decrease in the native one is more 
than 10, and ratios greater than 100 observed in about 25% of 
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cases [25]. This behavior has been observed also in in vitro 
evolution experiments, despite the fact that, in these cases, only 
one selection criterion was applied for the screening of evolved 
variants. 
The relative rates by which a new function is gained and the old 
one is lost have important consequences in molecular evolution; in 
principle, acquiring of a new enzymatic function by divergent 
evolution can proceed via a ‘generalist’ intermediate, that is an 
enzyme that exhibits a broad specificity, prior to generate a new 
specialist enzyme (Fig. 3) [25].  
Since in a living cell, the “cost” of a generalist enzyme on fitness 
might be quite high, that is a broad specificity enzyme might be 
toxic for the organism [26]. Thus the driving force for 
specialization is likely to be quite strong [25]. The accumulation of 
favorable mutations can proceed only as long as the activity of the 
native function is retained at a level high enough to not severely 
weaken the fitness of the organism. However, at the end of the 
evolutionary process, the acquisition of an efficient new activity is 
reached at the expense of the native one (Fig. 3). Thus, during the 
evolution of a new enzymatic function, at some point a gene 
duplication event becomes necessary in order to offer a margin 
that allows more beneficial mutations to accumulate, enabling the 
complete re-specialization of the diverging function. 
Thus it can be concluded that gene duplication is not a random 
event that happens in an early stage of the evolution of a novel 
enzymatic activity, but it is a positively selected event that 
happens in a later stage, to allow complete re-specialization of an 
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evolving protein. Furthermore, when an organism is forced to rely 
on a low promiscuous activity of an existing enzyme for its 
survival, the presence of a second gene copy that allows the 
production of an increased protein quantity, can grant an 
immediate selective advantage [2]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thus all existing proteins, no matter how different they can be in 
terms of sequence, structure or function, share a relatively low 
number of common ancestors and are related one to each other via 
Figure 3. Possible routes to acquire a new enzymatic function. The conversion of 
one specialist enzyme into another may follow either the concave or convex routes. 
In the latter (‘weak negative trade-offs’) large increases in the promiscuous function 
(‘new function’) are accompanied by significantly smaller decreases in the native 
function. The intermediates of these route are generalist enzymes, and their 
evolution can proceed prior to gene duplication. In the concave route, gene 
duplication is a necessary prerequisite, because acquisition of even low levels of the 
‘new’ function is accompanied by large losses of the original one. This route is 
observed in particular under a dual  selection, for the gain of a new function and the 
loss of the old one [25]. 
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a small number of ancestral polypeptides. An example of such 
sequence motifs is the P-loop, which is present in a large number 
of proteins from unrelated superfamilies, suggesting that this 
motif was present in the early protein ancestors [27]. 
In summary, it can be concluded that, when the selective pressure 
of the environment requires the generation of new enzymatic 
functions, nature exploits existing enzymes that already 
promiscuously catalyze this new reaction, tinkering with their 
active sites, to render it more suitable for the new substrate and 
reaction. Subsequently, following gene duplication, new family 
members diverge from existing ones, thus yielding the large and 
functionally diverse enzyme families and superfamilies we see 
today [25]. 
 
2 Flavoproteins 
Flavoproteins are proteins that use as cofactor a riboflavin derived 
nucleotide, such as flavin adenine dinucleotide (FAD) or flavin 
mononucleotide (FMN). 
To date, several hundreds of flavin-containing enzymes has been 
discovered. Flavins are very versatile coenzymes, that catalyze 
with considerable efficiency a wide variety of enzymatic reactions 
involving either two-electron or one-electron transfers. These 
reactions range from typical redox catalysis such as the 
dehydrogenation of an amino acid, the activation of dioxygen, 
photochemistry, DNA damage repair or light emission [28]. 
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2.1 The flavin cofactor and its chemical reactivity 
From a chemical point of view, flavins can be considered 
amphipathic molecules: the isoalloxazine system is formed by a  
hydrophobic xylene moiety, prone to interact with hydrophobic 
regions of the protein, and a pyrimidine ring that is relatively 
electron-deficient and hydrophilic and usually involved in 
hydrogen bonds with the protein. These interactions can differ 
substantially between the three redox states in which the cofactor 
can exist: oxidized, semiquinoid, and fully reduced, each one 
possessing peculiar spectral features (Fig. 4) [28]. 
 
 
 
 
 
 
 
  
 
 
The diversification of the reactions catalyzed by flavoproteins 
derives from the interaction of the isoalloxazine ring of the flavin 
cofactor with the protein scaffold. The redox potential of the two 
electron transfer at pH 7 is around -200 mV, but it can be lowered 
or increased, approximately in a 600 mV range, by the interaction 
with the protein: for example, a positive charge in the active site 
close to the pyrimidine ring contributes to raise the cofactor redox 
A B 
Figure 4. A) Representation of possible interactions between the isoalloxazine ring 
of the flavin and the protein. B) Different oxidation states of flavin cofactors [121]. 
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potential, while a negative charge or a hydrophobic environment 
tends to lower it [28].  
In free solution, the semiquinone form of the flavin is in very rapid 
equilibrium with the other two forms, with only a few percent of 
the total flavin being in this state [29, 30, 31], but when the flavin 
is bound to the protein, the semiquinone is generally stabilized 
and its neutral or the anionic forms can be observed; as an 
important consequence this allows the switch from two to one-
electron transfer reactions [32]. 
In addition to the polarity of the environment, the apoprotein 
affects the conformation of the isoalloxazine ring, since it can 
increase or decrease the typical bending of the molecule in the free 
form. In particular a clear distinction can be made between 
“classical” oxidase flavoproteins, which bind the cofactor in a non-
planar form and electron transferases which, in almost all cases, 
bind it in a planar state [32]. 
 
The variety of different reactions that can be catalyzed by 
flavoproteins is also reflected on the different reactivity toward 
molecular O2. Enzymes belonging to class 2 (see section 2.2 for 
classification of flavoproteins), for example, directly catalyze a 
two-electron reduction of O2 to yield H2O2 as product [33], while in 
class 3 monooxygenases the primary product of reaction is a flavin 
C4a-peroxide adduct [34, 35, 36]. Class 1 transhydrogenases and 
electron-transferases belonging to classes 4 and 5 (which carry out 
one-electron transfers) react with O2 producing the superoxide 
anion (O2-) and the neutral semiquinone flavin radical [32, 33]. In 
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addition, another class of flavoproteins (i.e. amino acid 
deaminases) are not able to react directly with oxygen, but employ 
alternative electron acceptors [37]. 
According to recent data, O2 appears to be able to directly interact 
with the flavin C4a atom, both in the monooxygenases and in the 
oxidases active sites, suggesting that, independently of the reaction 
mechanism, the C4a atom could be the locus directly involved in 
the transfer of electrons from the reduced cofactor to O2 [38]. As a 
general rule, the different oxygen reactivity of the members of 
different flavoprotein classes resides in the charge distribution 
around the isoalloxazine ring of the flavin and in its accessibility 
[39]. 
 
Another important reaction that can be used for the functional 
characterization of flavoproteins is the formation of a covalent but 
reversible adduct between sulfite and the N5 of the flavin. This 
reaction is not thermodynamically favorable in free flavins and 
thus low affinity for sulphite is retained in the majority of protein-
bound flavins [40]. There is, however, an exception: oxidases 
belonging to class 2 show a significant high reactivity with sulfite 
and in some cases the formation of the N5-sulfite adduct occurs 
with stoichiometric concentrations of this compound [41]. 
Interestingly, a correlation was observed between the reactivity 
with sulfite and the type of flavin radical which is stabilized by the 
enzyme: the stabilization of the anionic semiquinone flavin species 
coincides with high thermodynamic stabilization of the sulfite 
adduct, while the stabilization of the neutral semiquinone (or no 
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flavin radical stabilization) is concomitant with very low or no 
sulfite affinity [32]. 
 
2.2 Classification of flavoproteins 
Since flavoproteins are mainly involved in dehydrogenation or 
oxidation reactions, the oxidized form of the cofactor must be 
regenerated at the expense of the reduction of an electron 
acceptor. The acceptor might be a disulphide containing molecule, 
an oxidized nicotinamide nucleotide or an unsaturated compound 
such as fumarate or crotonyl-CoA, but in the majority of cases, the 
acceptor is molecular O2 or a redox protein such as an iron-sulphur 
containing protein or a cytochrome. In the latter case, the 
flavoprotein acts as a mediator between a two-electron and a one-
electron transfer step; this peculiar feature is almost unique in the 
metabolism of the cell [32]. 
 
Flavoproteins can be classified according to their function, in five 
major classes:  
Class 1 – Transhydrogenases. The enzymes catalyze a two-electron 
redox reaction by hydrogen transfer between two redox centers; 
class 1 flavoproteins can be further subdivided into 4 subclasses: 
carbon-carbon transhydrogenases, carbon-sulphur 
transhydrogenases, carbon-nitrogen transhydrogenases and 
nitrogen-nitrogen transhydrogenases. 
Class 2 - Dehydrogenases/oxidases. Flavoproteins belonging to 
this class are considered the “canonical” oxidoreductases. They 
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combine the dehydrogenation of a substrate with the reduction of 
molecular O2 to generate H2O2.  
Class 3 - Dehydrogenases/oxygenases. These enzymes differ from 
the previous ones in the reactivity with molecular O2. Class 3 
flavoproteins do not produce hydrogen peroxide, but one atom of 
the oxygen molecule is reduced to a water molecule, while the 
other one is incorporated into the second substrate of the enzyme. 
Class 4 - Dehydrogenases/electron-transferases. The enzymes 
accept two-electrons from a donor (e.g. a two electron-reacting 
nicotinamide nucleotide) and transfer them to a one-electron 
acceptor (e.g. a one-electron-reacting heme or iron-sulphur 
containing protein). 
Class 5 - Pure electron-transferases. This class of flavoproteins is 
formed by enzymes such as flavodoxins, which are involved 
exclusively in one-electron transfers [32]. 
 
In addition to their function, flavoproteins can be classified also on 
the basis of the architecture of their three-dimensional structure 
[42]. 
 
2.3 D-amino acid oxidases 
D-amino acid oxidase (DAAO EC 1.4.3.3), is a FAD-dependent 
peroxisomal enzyme, discovered more than 70 years ago by Krebs 
[43]. From a biochemical point of view, the enzyme has been 
extensively studied between 1950 and 1990 using the protein 
purified from pig kidney (pkDAAO) [44]. For this reason DAAO is 
considered a paradigmatic example of the class 2 of flavoproteins 
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[45]. DAAO catalyzes the strictly stereospecific oxidative 
deamination of D-amino acids to the corresponding imino acids 
which are non-enzymatically hydrolyzed to yield the 
corresponding α-keto acids and ammonium. The reduced FAD 
cofactor is then reoxidized by molecular oxygen, with production 
of hydrogen peroxide [46].  
 
2.3.1 Sources and physiological role of D-amino acid oxidases 
DAAO is mainly present in eukaryotic organisms. The enzymes 
from the yeast Rhodotorula gracilis (RgDAAO) and Trigonopsis 
variabilis (TvDAAO) have been purified and characterized in detail, 
also because of their biotechnological importance [47, 48].  
D-amino acid oxidase activity has been identified also in almost all 
the higher eukaryotes, with the possible exception of plants. 
During the years, several mammalian DAAOs have been 
characterized (e.g., from pig, rat, human) and, the 3D structure of 
some of them is available [50, 51, 52]. 
In yeast this enzyme allows the use of D-amino acids as a carbon, 
nitrogen, and energy source [47]. In mammals the physiological 
role of DAAO has not yet been fully elucidated. It is plausible that 
even in the same organism it performs different tissue specific 
roles. For example, it was proposed that, in liver and kidney DAAO 
acts as a detoxifying agent by oxidizing endogenous or exogenous 
D-amino acids. In the human brain DAAO is involved in the 
regulation of the metabolism of D-serine, a modulator of the 
glutamatergic neurotransmission [53]. 
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The highest level of mammalian D-amino acid oxidase 
overexpression in E. coli has been achieved for pig kidney DAAO 
(200-300 U/L of culture broth) [54]. On the other hand, better 
results have been obtained with RgDAAO which was expressed in 
E. coli with a volumetric yield of about 2300 U/L of culture [48]. 
 
2.3.2 Biochemical properties of D-amino acid oxidases 
DAAO is specific of apolar D-amino acids whereas it shows little to 
no activity versus polar and charged D-amino acids. For example, 
the best substrates of RgDAAO are D-Met, D-Trp and D-Ala [55].  
DAAO is able tostabilize the anionic semiquinone flavin species 
and shows a high reactivity with sulfite [32]. The protein is usually 
present in solution as a stable homodimer, with few exceptions 
(e.g. in the case of TvDAAO or pkDAAO) [44, 57]. DAAO monomer 
is formed by two domains, the FAD-binding domain, encompassing 
the Rossman fold, and the substrate binding domain. The FAD 
cofactor is non-covalently bound to the apoprotein  dissociation 
constants that range from 0.02 μM for RgDAAO to 10 μM for 
hDAAO [46]. It has been shown that the dimerization in RgDAAO 
increases the protein stability and the affinity for the cofactor and 
also results into a 10-fold higher enzymatic activity [58]. 
 
2.4 L-amino acid oxidases 
Similarly to DAAOs, L-amino acid oxidases (LAAOs, EC 1.4.3.2) are 
enzymes belonging to the class 2 of flavoproteins 
(dehydrogenases/oxidoreductases). According to the sequence 
and structure of the FAD-binding domain, LAAOs are classified as 
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members of the large glutathione reductase 2 (GR2) structural 
subfamily of flavoproteins [42]. The first LAAO has been described 
more than 70 years ago by Zeller and Maritz (1944) [59]. LAAOs 
catalyze the strictly stereospecific oxidative deamination of a wide 
range of L-amino acids to form the corresponding imino acids with 
the concomitant reduction of the flavin cofactor (reductive half 
reaction). The imino acid then undergoes a non-enzymatic 
hydrolysis, yielding an α-keto acid and ammonium. In most cases 
the reduced cofactor is reoxidized by molecular oxygen (oxidative 
half-reaction), generating hydrogen peroxide [60] (Fig. 5). 
 
 
 
 
 
 
 
Some membrane-bound L-amino acid oxidases, such as the ones 
from the Proteus genus, are associated with the respiratory 
electron transport chain and their flavin cofactor is reoxidized by 
an electron acceptor different from O2 [61, 62]. In turn this 
acceptor donates electrons to the membrane quinone pool through 
which they are transferred to a terminal cytochrome oxidase to 
reduce molecular oxygen to H2O [63]. 
LAAOs are found in almost all taxonomic kingdoms, ranging from 
bacteria species to algae, fungi, insects, mollusks, fishes, as well as 
snakes and mammals (in which it is mainly expressed in liver, 
Figure 5. Reaction catalyzed by L-amino acid oxidases. 
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kidney, nervous system, mammary gland and leukocytes) [64], 
[65]. From a biochemical point of view, LAAOs can be classified 
based on different properties: substrate specificity, molecular 
mass, regulation of expression, presence of post-translational 
modification and subcellular localization (i.e. intracellular, 
membrane bound, or extracellular) [66]. 
 
2.4.1 Snake venom L-amino acid oxidases 
Snake venom LAAOs (svLAAOs) are the best-studied members of 
this enzyme family. These enzymes are generally classified as N-
terminal FAD or FMN-bound reductases. They possess two highly 
conserved glutamine rich motifs involved in nucleotide-binding at 
the N-terminus of the protein [66]. The cofactor is usually non-
covalently bound to the apoprotein moiety [67]. Their relative 
abundance in snake venom varies depending on the species of the 
reptile, but in general, they are present in high concentration 
especially in the venom of Viperidae, Crotalidae and Elapidae 
snakes, where they can account for up to 9% of total venomic 
proteins [68]. 
Most svLAAOs are active over a wide range of pH and temperature 
and show a preferential catalytic specificity toward long chain 
hydrophobic or aromatic amino acids such as L-Phe, L-Met, L-Leu 
and L-Ile [69, 70]. In general their affinity for polar and basic L-
amino acids is low, especially for positively charged amino acids 
such as L-lysine and L-arginine, which form unfavorable 
electrostatic interactions with the residues of the catalytic site of 
the enzyme [71]. However, some LAAOs are active on charged 
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substrates: for example L-Lys is the best substrate for Ophiophagus 
hannah LAAO [72], and acidic amino acids L-Asp and L-Glu are the 
more efficient substrates for Bungarus fasciatus LAAO [73]. 
The isoelectric point of different svLAAOs ranges from 4.4 to 8.5; 
their isoelectric point also affects their pharmacological properties 
such as their anti-viral or bactericidal activity and their effect on 
the modulation of platelet aggregation. In the snake venom from 
the same species, acidic, neutral and basic forms of svLAAOs can 
coexist [74]. 
In general svLAAOs are homodimeric or, less frequently, 
monomeric proteins [68]; the molecular mass of each monomer 
ranges approximately from 50 to 70 kDa corresponding to a 
molecular mass of the dimer from 110 to 150 kDa [60]. 
SvLAAOs are extensively glycosylated proteins: they present a 
variable percentage of covalently linked sugars, which can widely 
vary according to the snake species: it can range from about 2% of 
the total protein mass in Crotalus adamanteus LAAO to up to 25% 
in the enzyme from Bungarus caeruleus [60]. This post-
translational glycosylation is proposed to play a role in the 
enzymatic and biological activity of these enzymes: indeed, the 
activity of LAAO from Agkistrodon halys pallas was decreased by 
about 75% when treated with peptide-N-glycosidase F, an enzyme 
which removes carbohydrates covalently linked to the protein 
[75]. Nonetheless, the specific role of glycosylation and its effect on 
the modulation of svLAAO activity is still unclear. 
The role of svLAAOs is to enhance the toxic effect of snake venom, 
by the extracellular oxidation of the free L-amino acids and 
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generation of hydrogen peroxide, a reactive oxygen species [64]. 
H2O2 then could act on cell membranes by altering the 
permeability of the attacked area, thus stimulating local necrotic 
or apoptotic processes, but the precise action mechanisms remain 
still unclear [76]. Consequences of svLAAO activity are edema and 
hemorrhage due to apoptosis of vascular endothelial cells and 
changing of the state of platelet aggregation [68]. 
 
2.4.1.1 Three-dimensional structure of eukaryotic L-amino 
acid oxidase. 
In 2000 Pawelek solved the three-dimensional structure of LAAO 
from the Malayan pit viper Calloselasma rhodostoma  (CrLAAO) in 
complex with two different inhibitors, citrate and anthranilate (2-
amino benzoate) [67]. CrLAAO is a homodimer: each monomer 
possesses a molecular mass of about 55 kDa and non-covalently 
binds one molecule of FAD. CrLAAO is glycosylated at Asn172 and 
Asn 361 (Fig. 6A). Each monomer is composed of three domains: a 
FAD-binding domain which contains the typical nucleotide binding 
motif, a substrate binding domain and an additional α-helical 
domain which contributes to the formation of a funnel that 
constitutes the entrance to the active site. The isoalloxazine moiety 
of the FAD cofactor is located at the interface between the FAD and 
substrate binding domains and forms extensive interactions with 
the protein scaffold. In particular the xylene motif is surrounded 
by hydrophobic residues, (Ile374, Trp420 and Ile430), while the 
pyrimidine ring forms hydrogen bonds with Met89, Arg90 and 
several crystallographic water molecules. The structure of the 
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enzyme in complex with the inhibitor anthranilate gives 
information on the binding mode of the natural substrates and on 
the reaction mechanism: the C1 of the inhibitor molecule, which 
mimics the Cα of the substrate, is positioned in proximity of the N5 
of the isoalloxazine ring of FAD, at an ideal distance for direct 
transfer of a hydride from the substrate to the cofactor [67]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
The ligand binding is stabilized by a salt bridge between Arg90 and 
the inhibitor carboxylate group, which is also hydrogen bonded 
with the hydroxyl group of the side chain of Tyr372. The aromatic 
ring of the ligand is sandwiched between the side chains of Ile430 
and Ile374 and the amino group is positioned over the pyrimidine 
portion of the isoalloxazine ring, within hydrogen bonding 
distance with the backbone carbonyl oxygen atom of Gly464 (Fig. 
6B) [67]. 
Figure 6. 3D structure of CrLAAO. A) Ribbon representation of CrLAAO dimer. 
Individual monomers are colored in red and green. FAD cofactor and glycosylation 
residues are shown in ball and stick representation. B) Detail of CrLAAO active site. 
The FAD cofactor is colored in gray and  relevant interacting residues are labelled 
and colored in yellow. Water molecules are represented as red spheres, while dotted 
lines represent hydrogen bonds. Protein backbone is in green [67]. 
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2.4.2 Microbial L-amino acid oxidases 
The first microbial LAAO activity (from the bacterium Proteus 
vulgaris) was described by Stumpf and Green in 1944 [77]. Since 
then, an increasing number of LAAOs from different 
microorganisms have been reported, but only in 1994 the first 
LAAO activity from a microorganism (the Gram-positive bacterium 
Bacillus carotarum) could be purified to homogeneity and 
characterized [78]. 
 
2.4.2.1 General properties of microbial L-amino acid oxidases 
Several microbial LAAOs exhibit a broad substrate specificity [79]. 
Typically they display a noticeable preference for hydrophobic 
amino acids such as L-Phe, L-Leu, L-Tyr and L-Trp [63]. A second 
group of LAAOs is formed by enzymes showing a very strict 
preference for a specific substrate (such L-aspartate oxidase). The 
stereospecificity of LAAOs is generally very strict; only few of them 
are active on some D-amino acid, but with negligible reaction rates 
in comparison to the ones of the corresponding L-amino acids [65]. 
Microbial LAAOs show an isoelectric point which varies from pH 
4.0 to 9.4 and a molecular mass between approximately 50 and 
300 kDa. They are usually present in solution as homodimers, 
formed by monomers that span from about 55 to 74.7 kDa and 
non-covalently bind one molecule of flavin cofactor in an extended 
conformation [63]. 
So far, four 3D structures of microbial LAAOs have been described: 
the structure of LAAO from R. opacus (RoLAAO), of L-glutamate 
oxidase (LGOX) from Streptomyces sp. X-119-6 and of L-aspartate 
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oxidases (LASPO) from thermophilic archaea Sulfolobus tokodaii  
and from Escherichia coli (the R386L variant). In all cases each 
LAAO subunit consists of three domains: a dinucleotide binding 
domain, containing the Rossman fold, a substrate binding domain 
and an additional helical domain. This topology is similar to the 
one described for snake venom LAAO [67]. 
All microbial LAAOs whose 3D structure is known are synthesized 
as precursors carrying a signal peptide and then converted into the 
mature proteins by limited proteolysis triggered by an 
endopeptidase [80]. This occurs after protein secretion and 
represents a strategy to prevent cellular apoptosis due to 
depletion of L-amino acids and H2O2 production in the cytoplasm. 
 
2.4.2.2 Biological functions of microbial L-amino acid oxidases 
Since most LAAOs from microorganisms are active versus a broad 
spectrum of substrates, it is plausible that they are involved in the 
utilization of such compounds as nitrogen and/or carbon source. 
In fact, microbial LAAOs (especially membrane bound forms), are 
functionally linked with metabolic pathways that allow an efficient 
catabolism of free amino acids [65]. As an example, in a number of 
unicellular algae, the presence of cell-surface LAAOs allow the 
growth of these organisms using free amino acids as the sole 
nitrogen source [81]. In addition, expression of LAAO in 
Neurospora crassa can be induced by the presence of L-Arg and L-
Phe in the culture broth (in the absence of other readily available 
nitrogen compounds) [82]. 
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The ability of LAAOs to produce H2O2 during the oxidation of L-
amino acids is also by some microorganism to gain a selective 
advantage. For example, Streptococcus oligofermentans was 
proposed to use this enzyme to outcompete other microorganisms 
in the oral cavity [83]. 
2.4.2.3 L-amino acid oxidase from Rhodococcus opacus 
(RoLAAO) 
R. opacus strain DSM 43250 is one of the best microbial LAAO 
producers. RoLAAO is purified from the native source by two ion 
exchange chromatography steps, separated by a hydrophobic 
interaction chromatography; this protocol allows to recover about 
68% of the enzymatic units with, with a purification factor of 144. 
RoLAAO specific activity is about 4.6 U per mg of protein on L-Ala 
[79]. This flavoprotein is homodimeric in solution, with a 
molecular mass of 54 kDa for the monomer and has an isoelectric 
point of 4.8. Each protein monomer possesses a N-terminal signal 
peptide of 45 amino acids which is cleaved in the mature form of 
RoLAAO; in spite of the presence of this putative secretion 
sequence the mature protein was detected only in the cell 
cytoplasm [79]. The protein stability at 37 °C is 20-fold enhanced 
when the protein is incubated in a glycine/NaOH buffer, but in 
these conditions the specific activity on L-Ala was significantly 
decreased because of competitive inhibition by glycine. 
Interestingly, the storage of RoLAAO frozen at -20 °C completely 
inactivates the enzyme [79]. 
To date, RoLAAO possesses the broadest substrate specificity 
among known L-amino acid oxidases (Fig. 7). 
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This flavoenzyme is active on 39 different L-amino acids, including 
17 of the 20 proteinogenic ones (the only exceptions being L-Thr, 
L-Pro and Gly). RoLAAO preferred substrates are aliphatic, 
aromatic and basic amino acids, namely L-alanine, L-1-naphtyl 
alanine and L-ornithine; for several of these substrate a Km in the 
order of 10-6 M was calculated. RoLAAO is strictly stereoselective: 
in fact, in it is not able to oxidize D-amino acids. Given the very 
wide substrate specificity, RoLAAO turned out to be very 
interesting for biotechnological applications such as the resolution 
of racemic mixtures: preliminary trials were performed on D,L-Leu 
and D,L-Phe mixtures (in the presence of an excess of catalase to 
prevent inactivation of the enzyme by hydrogen peroxide). In both 
cases an excellent enantiomeric excess was obtained (>99.2% and 
>99.5%, respectively) [79]. 
Figure 7. Comparison of RoLAAO specific activity versus the 20 
proteinogenic L-amino acids. 
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The three-dimensional structure of RoLAAO has been determined 
at 1.4 Å resolution (Fig. 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The general fold of RoLAAO is similar to the one of CrLAAO. It is a 
member of the gluthathione reductase (GR2) subfamily. Each 
monomer is composed of three domains: an FAD-binding domain 
which contains the Rossmann fold motif, a substrate binding 
domain and a helical domain, mainly responsible for protein 
dimerization.  
One main difference with the LAAO from C. rhodostoma is the lack, 
in RoLAAO, of a narrow active site funnel; instead, the active site is 
exposed to the solvent and the substrate entry is limited only by 
diffusion, also explaining its broader substrate specificity [84]. 
Furthermore, the 3D structure of the complex between RoLAAO 
and the substrate L-Ala provided further evidence on the general 
Figure 8. 3D structure of RoLAAO. A) Ribbon representation of the dimer of LAAO from 
R. opacus. The monomers are coloured in blue and cyan. The FAD molecules are shown 
as stick models. B) The active site of RoLAAO in binary complex with the FAD, shown as 
ball-and-stick models: carbon atoms are in yellow, nitrogen in dark blue and oxygen in 
red. Water molecules are shown as red spheres, H-bonds as dotted lines [84]. 
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catalytic mechanism of L-amino acid oxidases: in fact, the 
proximity of the α carbon atom of the substrate to the FAD N(5) 
atom, and the absence of a functional group that could work in 
acid-base catalysis, clearly point towards a hydride transfer 
mechanism [84]. 
Attempts to overexpress RoLAAO in E. coli led to accumulation in 
inclusion bodies [85]. On the other hand, RoLAAO was successfully 
expressed in the actinomycete Streptomyces lividans, a 
microorganism evolutionarily close to the native strain R. opacus. 
The heterologous protein possesses a slightly better specific 
activity versus L-Ala than the native one (5.4 U per mg of protein), 
but the purification yield was lower: only 27 % of the enzymatic 
units could be recovered from the crude extract. Native and 
recombinant RoLAAO possess the same molecular mass and 
biochemical and spectral properties. Interestingly, RoLAAO is 
purified from S. lividans cultures in two different mature forms, 
with the deletion of 38 or 44 aminoacids at the N-terminus, 
respectively; this has been proposed to be due to the presence of 
different signal peptidases system of S. lividans [85]. 
 
2.4.2.4 Aminoacetone oxidase from Streptococcus 
oligofermentans (SoAAO) 
The main strategy employed by S. oligofermentans to outcompete 
other Streptococcus species, such as Streptococcus mutans, is the 
production of H2O2 through oxidation of lactate catalyzed by 
lactate oxidase (lox). S. oligofermentans lox- mutants, though, still 
retained the ability to inhibit S. mutans growth. The product of the 
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aaoSo gene, an L-amino acid oxidase (SoAAO), was proposed to be 
responsible for this behaviour. In fact the ΔaaoSo mutant is not 
anymore able to outcompete S. mutans in interpecies antagonism 
experiments (Fig. 9) [83]. 
 
 
 
 
 
 
 
 
 
 
SoAAO was overexpressed as a recombinant protein in E. coli 
BL21(DE3)pLysS strain with the addition His6-tag sequence at the 
N-terminus to allow its purification by immobilized metal affinity 
chromatography. The molecular mass of the protein is 44.9 kDa. 
Production of H2O2 by SoAAO was observe only in the presence of 
L-Asp, L-Trp, L-Lys, L-Ile, L-Arg, L-Asn and L-Gln, while no H2O2 
was detected in the presence of other proteinogenic L-amino acids 
or the derivates N-acetyl-L-cysteine and cis-4-hydroxyl-L-proline 
[83]. 
In a more recent study, the aaoSo gene was shown to constitute an 
operon with MutT, a gene encoding for the 8-oxo-dGTPase, an 
enzyme involved in the elimination of harmful oxidized 
nucleotides. Deletion of both aaoSo and MutT genes causes a 
Figure 9. Growth inhibition of  
Streptococcus mutans by Streptococcus 
oligofermentans. 10 μl of overnight 
culture of S. oligofermentans and S. 
mutans at the same OD600 were spotted 
adjacently on peptone-present TPYG 
agar plates and incubated at 37°C for 24 
hours. A) Inhibition of S. mutans by wild 
type S. oligofermentans. (B) Inhibition of 
S. mutans by Δaaoso S. oligofermentans 
variant. Adapted from [81]. 
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significant reduction in S. oligofermentans growth rate, due to an 
increase in the concentration of reactive oxygen species in the cell, 
confirming that this operon might constitute a safeguard 
mechanism protecting cells from ROS damage in S. 
oligofermentans [86]. 
Since aminoacetone can be considered an analog of amino acids, 
the activity of SoAAO was tested on this compound: indeed, by 
using 25 mM of aminoacetone, a specific activity of about 48 mU 
per mg of protein could be detected. In parallel, SoAAO activity 
versus L-amino acids such as L-aspartate and L-lysine was found 
to be about 20-fold lower than the value reported in the previous 
work, while no activity on L-glutamine could be detected. For this 
reason SoAAO was newly classified as an aminoacetone oxidase 
(AAO) and its physiological role was revised [87]. In fact, this 
enzyme is possibly involved in aminoacetone detoxification, a role 
that in mammals is carried out by semicarbazide-sensitive amine 
oxidase (SSAO) [88]. Aminoacetone is a pro-oxidant by-product of 
threonine metabolism, and is able to react rapidly with oxygen 
through a superoxide-mediated mechanism [87] (Fig. 10).  
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2.4.2.5 L-amino acid deaminase from Proteus myxofaciens 
(PmaLAAD) 
L-amino acid deaminase is an enzyme that catalyze the oxidative 
deamination of L-amino acids without the production hydrogen 
peroxide. 
Previous reports showed that the genome of microorganisms 
belonging to genus Proteus contains two separate L-amino acid 
deaminase genes [61, 62]. The enzymes coded by these two genes 
differ in their substrate specificity: one enzyme, termed PmaLAAD, 
prevalently deaminates a wide range of aliphatic and aromatic 
amino acids, whereas the second one, Pm1LAAD, shows activity on 
Figure 10. Metabolic pathway involving SoAAO and MutT in preventing oxidative 
damage to cells. The absence of  SoAAO causes the accumulation of aminoacetone, 
which derives from threonine by threonine dehydrogenase(Tdh). It generates 
superoxide anions in the presence of oxygen and transition metals such as Fe2+ and the 
formation of hydroxyl radicals from H2O2. These hydroxyl radicals oxidize nucleic acids, 
like dGTP to 8-oxo-dGTP, which is hydrolized by MutT to the harmless 8-oxo-dGMP, 
and so prevents cell damage. Adapted from [86]. 
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a narrower range of amino acids, mainly basic ones such as L-
arginine and L-histidine [89]. 
In 2001, the gene encoding for the LAAD from Proteus myxofaciens 
was cloned and overexpressed [90]. PmaLAAD is a 474 amino 
acids protein, with a molecular mass of about 51 kDa. 
Like canonical amino acid oxidases, the enzyme requires oxygen 
for enzymatic activity and produces both NH4+ and phenylpyruvate 
(when L-Phe is used as the substrate) (Fig. 11). Differently from 
canonical LAAOs, the enzyme does not produce H2O2 [90]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PmaLAAD is active on most of the 20 proteinogenic L-amino acids. 
Large apolar amino acids such as L-Phe, L-Met, L-Leu, L-Phe and L-
Trp are the preferred substrates. In addition, marginal activity was 
measured also for the D-enantiomer of some of the substrates [90]. 
Figure 11. Dependence of the activity of PmaLAAD from O2. The rate of 
phenylpyruvate formation from L-phenylalanine, monitored as the increase of 
absorbance at 320 nm; reactions were performed in the presence (filled circles) or in 
the absence (empty circles) of  O2 [90]. 
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The enzymatic activity of PmaLAAD (on L-Phe as a substrate) is 
highest at pH 7.5 a pH optimum similar to the one determined for 
other deaminases from Proteus species. The Km for L-Phe is 2.28 
mM with a Vmax of 0.26 U per mg of protein. This latter value is 
about 8-fold lower than the one reported for the LAAD from 
Proteus rettgeri (about 2 U/mg of protein) [61]. This discrepancy 
was related to a different grade of purity of the enzymes under 
investigations. In fact, LAAD is a membrane protein; computational 
analysis predicted that PmaLAAD is a type II membrane bound 
protein. Accordingly, following ultracentrifugation of the crude 
extract all PmaLAAD activity was retained in the membrane 
fraction (pellet). This centrifugation step resulted into a 3.4-fold 
purification of the protein [90]. 
In the last few years L-amino acid deaminases are gaining 
increasing interest for their application in biocatalytic processes, 
especially for the production of α-keto acids. In particular, the 
enzyme from Proteus vulgaris (active on apolar amino acids) has 
been recently employed in the production of two different 
compounds. In the first application, LAAD was employed for the 
production of α-keto-γ-methylthiobutyric acid (KMTB) from L-
Met. This compound is gaining increasing interest in the 
pharmaceutical industry for the treatment of colon cancer [91]. In 
a laboratory scale process, 70 g/L of L-Met were incubated with 20 
g/L of the whole-cell biocatalyst; the maximum yield (49.2 g/L of 
KMTB) was obtained after 20 hours of reaction at 40 °C and at pH 
8.0 [92]. The same LAAD has also been employed for the 
production of α-ketoisocaproate (KIC) from L-Leu. This compound 
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could be used in the therapy for chronic kidney disease and 
hepatitis B virus infection, providing patients with their daily 
requirement of L-Leu [93]. A 97.8 % conversion of L-Leu to KIC 
was obtained by incubating 13.1 g/L of L-Leu with 0.8 g/L of 
whole-cell biocatalyst for 16 hours at 35 °C and at pH 7.5. The yield 
of KIC was 12.7 g/L [94]. 
The LAAD from Proteus mirabilis (Pm1LAAD), which is active on 
charged L-amino acids was also employed for the production of α-
keto acids. The enzyme has been used in the whole-cell biocatalyst 
form for the production of  α-ketoglutarate (KG), a compound that 
can be used as a building block for the synthesis of N-heterocyclic 
compounds possessing antitumor activity [95], as an antioxidant 
or to enhance wound healing [96]. A yield of 4.65 g/L of α-KG was 
obtained from 15 g/L of L-Glu, after 24 hours of reaction at 40 °C 
and at pH 8.0 [97]. Furthermore Pm1LAAD was recently employed 
for the production of phenylpyruvic acid (PPA) from L-Phe. This 
compound is widely used in the pharmaceutical, food, and 
chemical industry [98]. In this latter case, a comparison between 
whole-cell and enzymatic processes was performed. The 
performances of the two systems were similar: the process which 
employed the isolated enzyme allowed the production of 2.6 g/L of 
PPA (corresponding to a 87 % conversion) by incubation of 3 g/L 
of L-Phe with 0.2 g/L of Pm1LAAD for 5 hours at 35 °C and at pH 
7.0, while whne the whole-cell biocatalyst was used, 3.3 g/L of PPA 
were obtained from 4 g/L of L-Phe (82.5 % conversion) after 6 
hours of reaction at 40 °C and at pH 7.4employing 1.2 g/L of cells. 
In general, the isolated recombinant Pm1LAAD showed few 
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advantages in comparison to the whole-cell catalysts, because of 
the absence of side-reactions and because the substrate can 
interact more easily with the enzyme without the need to diffuse 
through the cell membrane. On the other hand, the whole-cell 
catalyst showed a better thermal stability (Hou et al., 2015). 
 
3. Biocatalysis for the production of optically pure compounds 
The biological activity of a compound often depends on the 
configuration of its chiral centers, because usually the active site of 
an enzyme (or a receptor) is strictly enantioselective [100]. It 
follows that the employment of enantiomerically pure chiral 
compounds could allow the employment of lower dosages, 
resulting, therefore, to fewer side effects and improved efficacy. 
The market for chiral raw materials used as chemical building 
blocks or synthetic intermediates currently stands at $15 billion, 
with the pharmaceutical industry accounting for the major part of 
this value: about 80% of the active compounds that 
pharmaceutical companies have in the pipeline are chiral. Sales of 
optically active intermediates are increasing of 7–8% annually, 
making the production of such compounds a rapidly growing area 
in the fine chemical industry. This, in turn, caused the 
transformation of biocatalysis from a niche technology to a widely 
used manufacturing method, with the consequent increase of the 
demand for biocatalysts (especially for the industrial-scale 
manufacture of chiral compounds) [101, 102]. 
The methods for the preparation of enantiomerically enriched 
compounds are classified into two main categories: 
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asymmetrization of prochiral compounds and optical resolution of 
racemates. Kinetic resolution belongs to the latter category; it is a 
versatile process, already well-established, to prepare optically 
active compounds, but the inherent limitation of this approach of a 
maximum 50% yield represents an important obstacle for their 
use in manufacturing processes. In addition, also the separation of 
the product from the unreacted starting material is inevitable and 
could be laborious [100]. 
 
3.1 Dinamic kinetic resolution 
Dynamic kinetic resolution (DKR) can overcome the limitations of  
standard kinetic resolution. This method involves the combination 
of an enantioselective transformation with an in situ racemization 
process at the equilibrium. As a consequence, as the reacting 
enantiomer is depleted by the enantioselective reaction, the 
racemization equilibrium of the two substrates is constantly 
shifted (Fig. 12). The racemization step be either enzymatic or 
non-enzymatic. Both enantiomers of the starting racemic mixture 
can be converted to the desired product with 100 % yield and very 
high enantiomeric excess giving an important advantage for 
industrial applications [103]. 
 
 
 
 
 
 
Figure 12. General scheme 
of A) kinetic resolution B) 
dynamic kinetic resolution. 
SR, SS = substrate 
enantiomers; PR, PS = 
product enantiomers; [I] = 
achiral transition state of 
the racemization kR, kS = 
rate constants; kR >> kS, 
preferably irreversible 
[104]. 
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3.2 Deracemization 
During deracemization a racemate is converted into a non-racemic 
product with 100% theoretical yield without intermediate 
separation of materials [104]. In this process one enantiomer of a 
racemate can be converted to the other via one or more reactions. 
In this way a racemic mixture can be transformed to an optically 
pure solution without any net change in the composition of the 
molecule [100]. An attractive feature of this process is the 
simplicity of the system, due to the fact that protecting groups are 
not required and because of the absence of product inhibition 
[103]. Deracemization reactions usually involve oxidation-
reduction processes. In the first step, one enantiomer is 
enantioselectively oxidized to form an achiral intermediate, which 
subsequently is non-selectively reduced to give again the starting 
mixture in racemic form (Fig. 13). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Scheme of deracemisation of racemic α-amino 
acid solution, by combining an enantioselective amino acid 
oxidase (e.g. DAAO) with a non-selective chemical reducing 
agent adapted from [101]. 
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Cyclic repetition of this sequence of reactions leads to an overall 
chiral inversion of the reacting enantiomer to yield the mirror-
image counterpart as the final product in a 100% theoretical 
chemical and optical yield. Clearly, since this system requires two 
reactions working simultaneously into opposite directions (an 
oxidation and a reduction) its feasibility relies mainly on their 
compatibility in a single reactor [104]. 
 
3.3 D-amino acids 
D-amino acids (D-AAs) are rare in nature; they are present in 
peptide antibiotics synthesized by bacteria and fungi, including 
gramicidin D (D-Leu and D-Val). D-amino acids such as D-Ala, D-
Asp, and D-Glu, are present in the milk of ruminants and in many 
fermented foods such as cheese, wine, yogurt, and fish products, 
where they can be derived by microorganisms during 
fermentation [105]. Furthermore in the human brain D-serine and 
D-aspartate have different roles in the development and 
functionality of the central nervous system (e.g. modulating the 
function of N-methyl-D-aspartate receptors) [106]. In 2011, the 
Global Industry Analyst, Inc., released a research report on the 
global market of D-AAs predicting that the global market for D-AAs 
will reach 3.7 billion dollars by 2017. D-amino acids are commonly 
employed in the pharmaceutical industry, food industry, and 
cosmetics. For example, they are used in the synthesis of semi-
synthetic antibiotics, including traditional and new penicillin- and 
cephalosporin-derived antibiotics (i.e. D-Phe is used for the 
production of ampicillin and amoxicillin), giving them a longer 
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half-life. Additionally, D-AAs can enhance the activity of antibiotics 
against biofilms of clinical wound [105]. Interestingly several 
reports show that peptide inhibitors containing D-amino acids 
interfere with the aggregation of amyloid-β peptides, which are the 
major components of the plaque found in the brains of Alzheimer’s 
disease patients. Also free D-amino acids are of great medicinal 
value: D-phenylalanine, in fact, could be used to treat pain, 
depression and Parkinson’s disease [107], while D-proline 
derivatives could be used for the treatment of diseases such as 
Alzheimer’s disease, diabetes mellitus, familial amyloid 
polyneuropathy, scrapie, and Kreuzfeld-Jacob disease [108]. In 
addition, unnatural D-amino acids now play an increasingly 
significant role in the development of synthesis protocols for 
pharmaceutical applications (for example as resolving agents) 
[109]. D-amino acids are also used as intermediates for the 
production of nutritional compounds (i.e. D-Ala is used for 
sweetener alitame) [110]. Given the high commercial importance 
of amino acids, recently a lot of efforts have been put in the 
development of processes for the production of these molecules 
[102]. 
 
3.3.1 Production of optically pure D-amino acids 
The only efficient methods to produce enantiomerically pure D-
amino acids are either chemical synthesis or biocatalysis. 
The biocatalytic synthesis of D-amino acids can be performed by 
employing a number of different enzymes: oxidoreductases, 
aminotransferases, hydrolases, dehydrogenases. These enzymes 
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can act on different starting compounds, such as racemic mixtures 
of D,L-amino acid (also comprising N-acyl-D,L-amino acids), 
synthetic intermediates, such as D,L-hydantoin or D,L-amino acid 
amides, and prochiral substrates, such as α-keto acids [105]. 
i) One of the simplest strategies to synthesize D-amino acids from 
a racemic mixture is the employment of L-amino acid oxidase. The 
achiral imine produced by LAAO can be subsequently reduced by a 
non-enzymatic non-selective chemical reagent. Since only the L-
enantiomer of the racemic mixture is utilized by the oxidase, at the 
end of the reaction the accumulation of the D-enantiomer is 
obtained. Theoretically, using a highly enantioselective LAAO, only 
7 cycles are required to achieve an enantiomeric excess of > 99% 
[103, 111]. For example LAAO from Rhodococcus species AIU z-35-
1 was employed for the oxidation of several L-amino acids (e.g. L-
Glu, L-Phe, L-Lys, L-Leu, L-His L-Gln, L-Arg L-citrulline and L-
homoserine). In a “model” reaction, 50 mM L-amino acid solutions 
were fully converted into optically pure D-amino acids in 24 h at 
30 °C and pH 7.0, using 45 mU/ml of enzyme [112]. For the 
resolution of racemic mixtures of D,L-aspartic acid, a specific 
enzyme, L-aspartate oxidase from the thermophilic archaea 
Sulfolobus tokodaii, was employed; this enzyme possesses a high 
thermal and pH stability and shows no product inhibition under 
bioconversion conditions. In a typical reaction, a 50 mM D,L-Asp 
solution was quantitatively converted in 24 h at 37 °C and at pH 
10, with an enantiomeric excess higher than 99.5 %, using a 
relatively low amount of enzyme (300 mU/mL) [113] (Fig. 14). 
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Further developments in the development of novel deracemization 
include the stereoinversion of beta and gamma substituted amino 
acids, in which the diastereoisomers of the substrate are 
interconverted [114]. 
ii) Enantioselective biotransformations are also possible with 
amino acid dehydrogenases. D-amino acid dehydrogenases are 
NADPH-dependent oxidoreductases, which can catalyze the 
asymmetric reductive amination of α-keto acids (using ammonium 
as a substrate) to form their corresponding D-amino acids [115]. 
iii) Also aminotransferases have been used for the production of 
enantiomerically pure D-amino acids. These enzymes produce α-
amino acids from α-keto acids, using an amino donor such as L-Asp 
or L-Glu. Although they can achieve a theoretical 100% yield the 
actual outcome is typically lower, because the catalyzed reaction is 
at the equilibrium, unless the reaction product is removed from 
the reaction mixture. For example when L-Asp is employed as an 
amino donor, the generated oxaloacetate is decarboxylated to 
pyruvate, thereby shifting the equilibrium of the reaction in the 
desired direction [116]. 
Figure 14. Time course of 
reaction of StLASPO with a D,L-
aspartate mixture. Filled circle: 
conversion of L-aspartate. Filled 
square: enantiomeric excess. At 
different time points, 50 μL 
aliquots was taken from the 
reaction reservoir, derivatized 
with the OPA-NAC reagent, and 
analyzed by HPLC [113]. 
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iv) D-stereospecific amidohydrolases (e.g. N-acyl-D-amino acid 
amidohydrolase, D-amino acid amidase, D-aminopeptidase, and D-
hydantoinases) can be used for resolution of racemic amino acid 
amides, which are inexpensive intermediates derived from 
chemical synthesis, to yield D-amino acids. These enzymes can be 
employed only in kinetic resolution processes, since they react 
only with the D-enantiomers of the substrates and thus the 
theoretical yield of the biocatalytic process is 50 % [117]. In 
addition D-hydantoinases can also be used for the production of 
non-natural amino acids. In this process D,L-5-substituted 
hydantoins as starting material, easily obtained by chemical 
synthesis, are first hydrolyzed into their carbamoyl derivatives by 
D-hydantoinase and then converted into corresponding D-amino 
acids through a decarbamoylation reaction catalyzed by D-
carbamoylase [118]. 
 
3.4 Production and improvement of enzymes as biocatalysts 
Enzymes can be employed in biocatalytic processes, either as 
components of metabolically inactive cells or as isolated proteins. 
Both the systems allow to exploit the strict enantioselectivity of 
the enzymes and usually allow to carry out processes under 
moderate temperature and pressure in aqueous media and are 
therefore ideal for the industrial manufacturing of chemicals. 
Purified enzymes can be used alone or as a part of reaction 
cascades; using this approach non-natural biocatalytic pathways 
can be easily assembled in vitro from purified enzymes and 
coenzymes [119]. The use of isolated enzymes allows an easier 
 46 
 
monitoring and control of the reaction because of the direct 
substrate supply to the catalyst, without the necessity of 
substrate/product diffusion through the membrane when whole-
cell systems are employed. In contrast, whole cells contain 
complex metabolic pathways that can interfere with the desired 
reaction (or series of reactions) and may suffer from reduced 
viability because of the potential toxicity of lab chemicals and/or 
reaction products [101, 120]. Currently a major inconvenience in 
the utilization of enzymes in vitro is their laborious and costly 
production, which often makes the biocatalytic processes 
unsustainable, from an economical point of view, beyond the 
laboratory scale. Nonetheless, the growing knowledge on the 
molecular biodiversity of enzymes (e.g. the exploitation of 
recombinant enzymes from thermophilic organisms) coupled with 
the development of modern techniques in molecular biology and in  
protein engineering will increase the possibility to produce 
effective, stable and affordable enzymes for biotechnological 
applications [120]. 
The “ideal” biocatalyst should possess the following properties: i) a 
broad substrate specificity ii) a high kcat and a low Km for its 
substrate (possibly in the millimolar range) iii) a good stability 
over a wide range of temperatures, pHs and organic solvents iv) a 
high enantioselectivity with a selectivity E value (i.e. the ratio 
between the specificity constants for the two enantiomers) of at 
least 50 [111]. However, enzymes identified in nature rarely 
possess all of these features, and frequently the in vitro 
improvement of a fine-tuned and optimized biocatalyst turns out 
 47 
 
to be a necessary prerequisite for specific biotechnological 
utilization. 
The strategy for the development of new catalysts is relatively 
simple and consists in coupling systematic alterations in the 
structure of the molecule (obtained by protein engineering), with 
effective methods for high-throughput screening of the produced 
variants for the desired properties (e.g., a higher turnover number 
or more strict enantioselectivity).  
A typical enzyme consists of up to 1000 amino acids and thus the 
exhaustive variation of each of its amino acids is practically 
impossible since the number of possible variants that could, in 
principle, be produced exceeds even the potential of ultra-high-
throughput screening methods. Moreover, usually it is not obvious 
which residue, or combinations of residues, is important for 
determining specific features of the enzyme. For this reason in the 
last few years a protein engineering approach called “directed 
evolution” has been established. This process mimics natural 
evolution in vitro in order to evolve enzymes possessing improved 
properties for biotechnological applications. In the first stage of 
directed evolution of an enzyme, mutations are randomly 
incorporated into the corresponding gene to generate a library of 
enzyme variants which are then screened for the improvement of 
specific functional or structural features (e.g., a higher activity or 
reduced Km)[101, 111]. 
The advantage of this approach is that it does not require prior 
knowledge of the three-dimensional structure, or, in some cases, 
even of the sequence of the enzyme that has to be improved, since 
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the variants are selected simply by the possess of a specific 
(improved) feature (e.g. the ability to efficiently carry out a specific 
chemical reaction), without taking into account the structural 
determinants at the base of the observed changes. During the in 
vitro evolution processes, the high enantioselectivity of the native 
enzymes is usually retained, or even improved; in fact, variants of 
amino acid oxidases, screened primarily for an increase of their 
activity against a single enantiomer of the substrate, often retained 
also their high enantioselectivity [111]. 
Successful directed evolution projects rely on efficient and simple 
screening procedures. For this reason, this approach is especially 
suitable for enzymes that catalyze the production of colored 
products, easily detectable by means of colorimetric methods. For 
example, D- or L- amino acid oxidases produce hydrogen peroxide, 
which can be easily detected by a coupled spectrophotometric 
assay [102]. This makes the engineering of these enzymes (such as 
PmaLAAD) an ideal starting point for the generation of improved 
enzymatic variants by directed evolution approaches [103].
 49 
 
 
 
Aim of the 
work
 50 
 
In order to allow rapid adaptation to changing environmental 
conditions, such as the availability of different nutritional sources, 
organisms need to quickly develop new metabolic functions, 
which, in turn, require new enzymatic functions. Enzymatic 
promiscuity, that is the ability of enzymes to catalyze auxiliary 
reactions different from those for which they have evolved (and 
that are not part of the organism’s physiology), plays a key role in 
the divergent evolution of novel enzymes from existing ones [2]. 
Enzymes belonging to the large family of flavoproteins share a 
remarkable degree of condition, substrate and catalytic 
promiscuity. This property allowed flavoproteins to rapidly evolve 
and specialize to catalyze a wide range of new and different 
reactions, which range from metabolic redox reactions, electron 
transport, gene expression regulation, signal transduction and 
light running [28]. Among flavoproteins, amino acid oxidases 
(AAOs) are a group of FAD containing enzymes that catalyze the 
oxidative deamination of amino acids. During evolution, AAOs 
evolved from a common ancestor to fulfill very different 
physiological roles (e.g. the catabolism of amino acids or the 
regulation of neuromodulators). This remarkable divergent 
evolution was obtained by the reshaping of the functional and 
structural features of these enzymes. Thus AAOs represent thus an 
ideal model to understand the mechanisms that originated 
molecular biodiversity in modern enzyme families. In addition, the 
strict enantioselectivity of these enzymes renders AAOs 
interesting biocatalysts for the development of processes for the 
production of enantiomerically pure amino acids [45, 46, 63]. 
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D-amino acids are valuable compunds commonly used in semi-
synthetic antibiotics synthesis, including traditional and new 
penicillin- and cephalosporin-derived antibiotics, and they can be 
exploited to enhance the activity of antibiotics against microbial 
biofilms in clinical wounds. Moreover several reports show that   
D-amino acid based peptide inhibitors interfere with the 
aggregation of amyloid-β peptides. In the food industry D-amino 
acids are used as intermediates in the production of nutritional 
compounds, such as D-alanine in the sweetener alitame [105]. 
Unfortunately, up to now the lack of overexpression of known 
LAAOs as recombinant proteins, prevented their use for the 
devolpment of processes for the preparation of pure D-amino 
acids. 
 
The aim of this PhD project was the identification (through 
extensive literature and database research) and the 
characterization of novel microbial LAAOs possessing interesting 
characteristics, from a biochemical, structural and biotechnological 
point of view. The thorough investigation of these proteins will 
allow us to understand the structure/function relationships in this 
group of proteins, to clarify their physiological role and to obtain 
new insights on the underlying mechanisms of their molecular 
evolution. The information obtained from these studies will also 
allow to form a background for the structure-guided engineering 
of these proteins, in order to obtain a novel, improved biocatalyst.
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